Proceed with standard monitoring
Documentation appears reasonably organized, but continue routine refill-by-refill review and symptom tracking.
What this tool reviews
- Source/pharmacy details available in writing?
- Label clearly states active ingredient, concentration, and dosing units?
- Beyond-use date visible?
- Storage instructions visible?
- Package arrived intact and legible?
- Instructions match the clinician's plan?
- Recent source or formulation change?
- Clear same-day contact for quality or adverse-event concerns?
- Refill-by-refill documentation being kept?
Result buckets
Pause and clarify
One or more documentation or handling details are unclear. Pause and clarify in writing before the next dose.
Urgent escalation
The combination of documentation gaps and current uncertainty suggests the need for same-day clinician review or urgent evaluation if symptoms are also active.
Read next
Frequently Asked Questions
Should I run this checklist at every refill?
Yes. Refill familiarity is not a safety system, especially when labels, instructions, or source details change.
Does a lower price prove the pathway is acceptable?
No. Lower cost is not a safety signal. Documentation quality, contact clarity, and continuity still need to be verified.
What if the refill looks different but I need the next dose soon?
Pause and clarify the difference in writing before dosing. If the delay becomes the main issue, review GLP-1 Refill Interruptions as well.
When should I escalate the issue the same day?
Escalate the same day when the instructions do not match the plan, core label details are missing, or symptoms are worsening during the same period of uncertainty.
Start the next step
This tool is educational only. It reduces guesswork but does not replace clinician oversight, pharmacy review, or emergency care.